Evidence map›Paper›PMID 19655814›Full record

ArticleBiochemistry2009

Activation of membrane cholesterol by 63 amphipaths.

Yvonne Lange, Jin Ye, Mark-Eugene Duban, Theodore L Steck

Abstract readComparative Study
In one paragraph

Article in Biochemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. n-Alcohol Length Governs Shift in LBiophysical journal · 2017
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Yvonne LangeDepartment of Pathology, Rush University Medical Center, Chicago, Illinois 60612, USA. ylange@rush.edu
Jin Ye
Mark-Eugene Duban
Theodore L Steck
Rush University Medical Center · USNorthwestern University · USUniversity of Chicago · US

Funding

Transcriptional Analysis of a CAR Gene Family from Medicago sativaS06GM008043 · NIGMS · CHICAGO STATE UNIVERSITY · PI ERHART, MARK A · 1989 to 2010
$7.9M
THE DYNAMICS OF CHOLESTEROL IN MEMBRANESR01HL028448 · NHLBI · RUSH UNIVERSITY MEDICAL CENTER · PI LANGE, YVONNE · 1985 to 2012
$2.9M
DISPOSITION AND MOVEMENT OF CHOLESTEROL IN CELLSR55HL028448 · NHLBI · RUSH UNIVERSITY MEDICAL CENTER · PI LANGE, YVONNE · 1992 to 1992
–
NHLBI NIH HHS HL 28448NHLBI NIH HHS R01 HL028448NIGMS NIH HHS GM08043NIGMS NIH HHS S06 GM008043
6 · The paper itself

Abstract

A few membrane-intercalating amphipaths have been observed to stimulate the interaction of cholesterol with cholesterol oxidase, saponin and cyclodextrin, presumably by displacing cholesterol laterally from its phospholipid complexes. We now report that this effect, referred to as cholesterol activation, occurs with dozens of other amphipaths, including alkanols, saturated and cis- and trans-unsaturated fatty acids, fatty acid methyl esters, sphingosine derivatives, terpenes, alkyl ethers, ketones, aromatics and cyclic alkyl derivatives. The apparent potency of the agents tested ranged from 3 microM to 7 mM and generally paralleled their octanol/water partition coefficients, except that relative potency declined for compounds with >10 carbons. Some small amphipaths activated cholesterol at a membrane concentration of approximately 3 mol per 100 mol of bilayer lipids, about equimolar with the cholesterol they displaced. Lysophosphatidylserine countered the effects of all these agents, consistent with its ability to reduce the pool of active membrane cholesterol. Various amphipaths stabilized red cells against the hemolysis elicited by cholesterol depletion, presumably by substituting for the extracted sterol. The number and location of cis and trans fatty acid unsaturations and the absolute stereochemistry of enantiomer pairs had only small effects on amphipath potency. Nevertheless, potency varied approximately 7-fold within a group of diverse agents with similar partition coefficients. We infer that a wide variety of amphipaths can displace membrane cholesterol by competing stoichiometrically but with only limited specificity for weak association with phospholipids. Any number of other drugs and experimental agents might do the same.

Indexed as

beta-CyclodextrinsCells, CulturedCholesterolCholesterol OxidaseErythrocyte MembraneHemolysisHumansHydrophobic and Hydrophilic InteractionsHydroxymethylglutaryl-CoA-Reductases, NADP-dependentIntercalating AgentsPhospholipidsbeta-CyclodextrinsCholesterolCholesterol OxidaseHydroxymethylglutaryl-CoA-Reductases, NADP-dependentIntercalating Agentsmethyl-beta-cyclodextrinPhospholipids

Identifiers

PMID19655814
PMCPMC2739890
OpenAlexW2029576676

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.